Determinants of the efficacy of viro-immunotherapy: A review

被引：10

作者：

de Graaf, J. F. ^{[1
]}

Huberts, M. ^{[1
]}

Fouchier, R. A. M. ^{[1
]}

van den Hoogen, B. G. ^{[1
]}

机构：

[1] Erasmus MC, Virosci Dept, Rotterdam, Netherlands

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2020年 / 56卷

关键词：

Oncolytic viruses; Viro-immunotherapy; Clinical parameters; PHASE-I TRIAL; HERPES-SIMPLEX-VIRUS; CONDITIONALLY-REPLICATIVE ADENOVIRUS; TARGETED ONCOLYTIC POXVIRUS; PROOF-OF-CONCEPT; CLINICAL-TRIAL; CANCER-PATIENTS; TALIMOGENE LAHERPAREPVEC; VACCINIA VIRUS; MEASLES-VIRUS;

D O I：

10.1016/j.cytogfr.2020.07.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Oncolytic virus immunotherapy is rapidly gaining interest in the field of immunotherapy against cancer. The minimal toxicity upon treatment and the dual activity of direct oncolysis and immune activation make therapy with oncolytic viruses (OVs) an interesting treatment modality. The safety and efficacy of several OVs have been assessed in clinical trials and, so far, the Food and Drug Administration (FDA) has approved one OV. Unfortunately, most treatments with OVs have shown suboptimal responses in clinical trials, while they appeared more promising in preclinical studies, with tumours reducing after immune cell influx. In several clinical trials with OVs, parameters such as virus replication, virus-specific antibodies, systemic immune responses, immune cell influx into tumours and tumour-specific antibodies have been studied as predictors or correlates of therapy efficacy. In this review, these studies are summarized to improve our understanding of the determinants of the efficacy of OV therapies in humans and to provide insights for future developments in the viro-immunotherapy treatment field.

引用

页码：124 / 132

页数：9

共 78 条

[21] A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas [J].

Forsyth, Peter ;

Roldan, Gloria ;

George, David ;

Wallace, Carla ;

Palmer, Cheryl Ann ;

Morris, Don ;

Cairncross, Gregory ;

Matthews, Maureen Vallee ;

Markert, James ;

Gillespie, Yancey ;

Coffey, Matt ;

Thompson, Brad ;

Hamilton, Mark .

MOLECULAR THERAPY, 2008, 16 (03) :627-632

[22] Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme [J].

Freeman, AI ;

Zakay-Rones, Z ;

Gomori, JM ;

Linetsky, E ;

Rasooly, L ;

Greenbaum, E ;

Rozenman-Yair, S ;

Panet, A ;

Libson, E ;

Irving, CS ;

Galun, E ;

Siegal, T .

MOLECULAR THERAPY, 2006, 13 (01) :221-228

[23] Oncolytic virus therapy: A new era of cancer treatment at dawn [J].

Fukuhara, Hiroshi ;

Ino, Yasushi ;

Todo, Tomoki .

CANCER SCIENCE, 2016, 107 (10) :1373-1379

[24] Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma [J].

Galanis, Evanthia ;

Markovic, Svetomir N. ;

Suman, Vera J. ;

Nuovo, Gerard J. ;

Vile, Richard G. ;

Kottke, Timothy J. ;

Nevala, Wendy K. ;

Thompson, Michael A. ;

Lewis, Jean E. ;

Rumilla, Kandelaria M. ;

Roulstone, Victoria ;

Harrington, Kevin ;

Linette, Gerald P. ;

Maples, William J. ;

Coffey, Matt ;

Zwiebel, James ;

Kendra, Kari .

MOLECULAR THERAPY, 2012, 20 (10) :1998-2003

[25] Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer [J].

Galanis, Evanthia ;

Hartmann, Lynn C. ;

Cliby, William A. ;

Long, Harry J. ;

Peethambaram, Prema P. ;

Barrette, Brigitte A. ;

Kaur, Judith S. ;

Haluska, Paul J., Jr. ;

Aderca, Ileana ;

Zman, Paula J. ;

Sloan, Jeff A. ;

Keeney, Gary ;

Atherton, Pamela J. ;

Podratz, Karl C. ;

Dowdy, Sean C. ;

Stanhope, C. Robert ;

Wilson, Timothy O. ;

Federspiel, Mark J. ;

Peng, Kah-Whye ;

Russell, Stephen J. .

CANCER RESEARCH, 2010, 70 (03) :875-882

[26] A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients [J].

Garcia, Margarita ;

Moreno, Rafael ;

Gil-Martin, Marta ;

Cascallo, Manel ;

Ochoa de Olza, Maria ;

Cuadra, Carmen ;

Maria Piulats, Josep ;

Navarro, Valentin ;

Domenech, Marta ;

Alemany, Ramon ;

Salazar, Ramon .

HUMAN GENE THERAPY, 2019, 30 (03) :352-364

[27] Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection [J].

Garcia-Carbonero, Rocio ;

Salazar, Ramon ;

Duran, Ignacio ;

Osman-Garcia, Ignacio ;

Paz-Ares, Luis ;

Bozada, Juan M. ;

Boni, Valentina ;

Blanc, Christine ;

Seymour, Len ;

Beadle, John ;

Alvis, Simon ;

Champion, Brian ;

Calvo, Emiliano ;

Fisher, Kerry .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

[28] Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver [J].

Geevarghese, Sunil K. ;

Geller, David A. ;

de Haan, Hans A. ;

Hoerer, Markus ;

Knoll, Anette E. ;

Mescheder, Axel ;

Nemunaitis, John ;

Reid, Tony R. ;

Sze, Daniel Y. ;

Tanabe, Kenneth K. ;

Tawfik, Hoda .

HUMAN GENE THERAPY, 2010, 21 (09) :1119-1128

[29] Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial [J].

Geletneky, Karsten ;

Hajda, Jacek ;

Angelova, Assia L. ;

Leuchs, Barbara ;

Capper, David ;

Bartsch, Andreas J. ;

Neumann, Jan-Oliver ;

Schoening, Tilman ;

Huesing, Johannes ;

Beelte, Birgit ;

Kiprianova, Irina ;

Roscher, Mandy ;

Bhat, Rauf ;

von Deimling, Andreas ;

Brueck, Wolfgang ;

Just, Alexandra ;

Frehtman, Veronika ;

Loebhard, Stephanie ;

Terletskaia-Ladwig, Elena ;

Fry, Jeremy ;

Jochims, Karin ;

Daniel, Volker ;

Krebs, Ottheinz ;

Dahm, Michael ;

Huber, Bernard ;

Unterberg, Andreas ;

Rommelaere, Jean .

MOLECULAR THERAPY, 2017, 25 (12) :2620-2634

[30] Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck [J].

Harrington, Kevin J. ;

Hingorani, Mohan ;

Tanay, Mary Anne ;

Hickey, Jennifer ;

Bhide, Shreerang A. ;

Clarke, Peter M. ;

Renouf, Louise C. ;

Thway, Khin ;

Sibtain, Amen ;

McNeish, Iain A. ;

Newbold, Kate L. ;

Goldsweig, Howard ;

Coffin, Robert ;

Nutting, Christopher M. .

CLINICAL CANCER RESEARCH, 2010, 16 (15) :4005-4015

← 1 2 3 4 5 6 7 8 →